Drug recall · August 13, 2025
Doxepin Hydrochloride Capsules recall
Why: CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Doxepin Hydrochloride Capsules, USP, 10 mg, 100 Capsules, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panela v 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-637-31
- Lots / codes
Lot: 2305015142, Exp. Date: 9/30/2025
- Quantity
- 9,492 bottles
- Company
- Alembic Pharmaceuticals Limited, Panchmahal, N/A
- Distribution
- Nationwide in the USA.
- Initiated
- July 25, 2025 · Voluntary: Firm initiated
- Classified
- August 1, 2025
- Reported
- August 13, 2025
- How notified
- N/A
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Doxepin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.